Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease

Affiliations

• ¹ Second Medical Clinic, School of Medicine, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Macedonia, Greece.
• ² First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece.
• ³ Midwifery Department, School of Healthcare Sciences, University of West Macedonia, Kozani, Macedonia, Greece.
• ⁴ Hepatogastroenterology Unit, Second Department of Internal Medicine-Propaedeutic, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
• ⁵ Department of Gastroenterology, 401 General Military Hospital of Athens, Athens, Greece.
• ⁶ Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, Thessaloniki, Macedonia, Greece.
• ⁷ Gastroenterology Department, Theageneio Hospital, Thessaloniki, Macedonia, Greece.
• ⁸ Thalassemia Unit, 2nd Department of Internal Medicine, School of Medicine, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Macedonia, Greece.